The first United States patient has been treated with the J-Valve TF system designed to address one of the holes in the rapidly evolving TAVR field: the lack of devices specifically targeting pure aortic regurgitation.

With use of cardiac implantable electronic devices on the rise, experts stress device selection, prophylactic antibiotics, pre-procedural protocols and post-implementation vigilance.

Ramping up the battle against cardiovascular disease in women represents a golden opportunity to move the needle on mortality.

Will operators be able to replicate COAPT’s restraint and its outcomes?

For-profit and not-for-profit healthcare facilities may value the health of their cath lab employees differently. Without a clear indication of the bottom-line impact, some hospitals may be forgoing protective equipment and sacrificing the long-term health of their workers. Should the C-suite prioritize worker health when allocating investment dollars? 

Hypertensive patients who had periventricular white matter abnormalities progress from one brain scan to the next showed a six-fold increased risk of mild cognitive impairment, researchers reported Jan. 4 in Hypertension.

Compared to drug therapy alone, catheter ablation nearly halved the risk of death and improved a range of clinical outcomes for patients with both heart failure and atrial fibrillation (AFib) in a meta-analysis.

About one-quarter of adults in the world will experience a stroke in their lifetime, according to new estimates from the Global Burden of Disease Study published online Dec. 20 in the New England Journal of Medicine.